MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 23 filers reported holding MILESTONE PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,699,000 | +8.8% | 253,610 | +18.9% | 0.06% | +3.4% |
| Q3 2020 | $1,561,000 | +93.7% | 213,310 | 0.0% | 0.06% | +87.1% |
| Q2 2020 | $806,000 | +105.6% | 213,310 | 0.0% | 0.03% | +72.2% |
| Q1 2020 | $392,000 | -96.7% | 213,310 | -71.4% | 0.02% | -96.0% |
| Q4 2019 | $11,954,000 | +1372.2% | 746,653 | +1490.7% | 0.45% | +1191.4% |
| Q3 2019 | $812,000 | -40.2% | 46,940 | -6.1% | 0.04% | -36.4% |
| Q2 2019 | $1,358,000 | – | 50,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 1,750,043 | $11,464,000 | 1.71% |
| Novo Holdings A/S | 2,530,585 | $16,575,000 | 0.78% |
| Boxer Capital, LLC | 2,238,861 | $14,665,000 | 0.57% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,264,000 | 0.41% |
| RA Capital Management | 2,246,503 | $14,715,000 | 0.26% |
| Bleichroeder LP | 250,000 | $1,638,000 | 0.26% |
| PURA VIDA INVESTMENTS, LLC | 931,511 | $6,101,000 | 0.22% |
| Orbimed Advisors | 2,583,821 | $16,924,000 | 0.22% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,576,000 | 0.11% |
| Eversept Partners, LP | 147,165 | $963,931 | 0.06% |